Askel Healthcare Ltd
Our mission is to keep people in motion.
Our mission is to keep people in motion.
Askel Healthcare Ltd is a Finnish medical technology company founded in 2017 with the mission to keep people in motion. The company's groundbreaking innovation, the universal COPLA® implant, aims to transform surgical knee cartilage treatment and recovery. The company's focus on the health care industry reflects its commitment to improving patient outcomes and quality of life. In December 2021, Askel Healthcare secured a significant €2.50M grant investment from The European Innovation Council, highlighting its potential for growth and innovation in the medical technology sector. With its headquarters in Finland, Askel Healthcare is positioned to make a meaningful impact on the global healthcare landscape. Learn more about the company's mission and innovative solutions here.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | €2.50M | 1 |
|
17 Dec 2021 |
| Seed Round | €1.34M | 1 |
|
01 Jul 2021 |
| Seed Round | €510.00K | - | 14 Oct 2020 | |
| Equity Crowdfunding | €770.00K | - | 02 Jan 2020 | |
| Seed Round | €350.00K | - | 15 Feb 2018 |
No recent news or press coverage available for Askel Healthcare Ltd.
We care about your data, and we'd love to use cookies make your experience better.
